Inactive Instrument

Health Discovery Corporation Stock Other OTC

Equities

HDVY

US42218R1005

Biotechnology & Medical Research

Sales 2019 1.52M Sales 2020 1K Capitalization 18.27M
Net income 2019 1M Net income 2020 - EV / Sales 2019 6.91 x
Net cash position 2019 2.1M Net cash position 2020 705K EV / Sales 2020 17,568 x
P/E ratio 2019
12.5 x
P/E ratio 2020
-22.6 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Health Discovery Corporation Announces Retirement of William F. Fromholzer from the Board of Directors CI
Health Discovery Corporation Announces Demise of George Mcgovern, Chairman CI
Health Discovery Corporation Announces Demise of George Mcgovern, Chief Executive Officer CI
Health Discovery Corporation Announces Board Changes CI
Health Discovery Corporation Announces Resignation of Marty Delmonte as President, Chief Operating Officer and Director CI
Health Discovery Corporation announced that it expects to receive $0.41 million in funding CI
Health Discovery Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Health Discovery Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Health Discovery Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Health Discovery Corporation Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Health Discovery Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Health Discovery Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Health Discovery Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Health Discovery Corporation Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Health Discovery Corporation Appoints Mr. Marty Delmonte as President and Chief Operating Officer CI
More news
Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - 03-12-31
Members of the board TitleAgeSince
Director/Board Member 51 17-04-25
Director/Board Member 49 18-05-08
More insiders
Health Discovery Corporation (HDC) is an intellectual property development company that uses mathematical techniques to analyze data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the field of molecular diagnostics where such tools are used for scientific discovery. Its Support Vector Machine (SVM) assets in particular have applicability in various other fields. HDC's joint venture, SVM Capital, LLC (SVM Capital), applies SVM technology to the financial markets. The Company's principal asset is its intellectual property, which includes mathematical algorithms called SVM and Fractal Genomic Modeling (FGM), as well as biomarkers that the Company has developed by applying its SVM and FGM techniques to genetic and proteomic data. It also owns the assets of Fractal Genomics, LLC, a company with FGM software. The FGM data analysis technique enables the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases.
More about the company